The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells

Kai Werner, Sebastian Dolff, Yang Dai, Xin Ma, Alexandra Brinkhoff, Johannes Korth, Anja Gaeckler, Hana Rohn, Ming Sun, Jan Willem Cohen Tervaert, Pieter van Paassen, Andreas Kribben, Oliver Witzke, Benjamin Wilde*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number2843
Number of pages10
JournalFrontiers in Immunology
Volume10
DOIs
Publication statusPublished - 10 Dec 2019

Keywords

  • ANCA vasculitis
  • BTLA
  • co-inhibition
  • immune checkpoint
  • Th17 cells
  • T-LYMPHOCYTE ATTENUATOR
  • REGULATORY CD4+T CELLS
  • B-LYMPHOCYTE
  • PERIPHERAL-BLOOD
  • WEGENERS-GRANULOMATOSIS
  • ANTI-BTLA
  • EXPRESSION
  • TOLERANCE
  • ACTIVATION
  • INFILTRATE

Cite this

Werner, K., Dolff, S., Dai, Y., Ma, X., Brinkhoff, A., Korth, J., Gaeckler, A., Rohn, H., Sun, M., Tervaert, J. W. C., van Paassen, P., Kribben, A., Witzke, O., & Wilde, B. (2019). The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells. Frontiers in Immunology, 10, [2843]. https://doi.org/10.3389/fimmu.2019.02843